You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 20, 2024

Investigational Drug Information for Nirmatrelvir

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Nirmatrelvir?

Nirmatrelvir is an investigational drug.

There have been 23 clinical trials for Nirmatrelvir. The most recent clinical trial was a Phase 3 trial, which was initiated on January 21st 2023.

The most common disease conditions in clinical trials are COVID-19, Disease, and Severe Acute Respiratory Syndrome. The leading clinical trial sponsors are Pfizer, The Affiliated Hospital Of Southwest Medical University, and Eva Pharma.

There is one US patent protecting this investigational drug and forty-four international patents.

Recent Clinical Trials for Nirmatrelvir
RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID SymptomsKanecia Obie ZimmermanPhase 2
A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine RosuvastatinPfizerPhase 1
Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With ComorbiditiesNational Taiwan University HospitalPhase 2/Phase 3

See all Nirmatrelvir clinical trials

Clinical Trial Summary for Nirmatrelvir

Top disease conditions for Nirmatrelvir
Top clinical trial sponsors for Nirmatrelvir

See all Nirmatrelvir clinical trials

International Patents for Nirmatrelvir

Drugname Country Document Number Estimated Expiration Related US Patent
nirmatrelvir Argentina AR123111 2040-09-03 ⤷  Sign Up
nirmatrelvir Australia AU2021266232 2040-09-03 ⤷  Sign Up
nirmatrelvir Australia AU2022202158 2040-09-03 ⤷  Sign Up
nirmatrelvir Australia AU2022221493 2040-09-03 ⤷  Sign Up
nirmatrelvir Brazil BR112021022419 2040-09-03 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.